ContextVision AB (publ) (OSL:CONTX)

Market Cap	456.47M
Revenue (ttm)	142.90M
Net Income (ttm)	25.33M
Shares Out	77.37M
EPS (ttm)	0.33
PE Ratio	18.02
Forward PE	19.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,573
Average Volume	36,321
Open	5.70
Previous Close	5.90
Day's Range	5.70 - 5.90
52-Week Range	4.52 - 6.98
Beta	1.02
RSI	51.16
Earnings Date	Apr 11, 2025

About ContextVision AB

ContextVision AB (publ), a medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and America. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and veterinary uses. Its products include Rivent that offers image enhancement and visualization solutions for ultrasound systems for women’s health, general imaging, cardiovascular, and point of care applications; Rivent Mobile, a 2D image enhancement product for handheld units; a...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1983
• Employees: 35
• Stock Exchange: Oslo Børs
• Ticker Symbol: CONTX

Financial Performance

In 2024, ContextVision AB's revenue was 139.20 million, an increase of 4.98% compared to the previous year's 132.60 million. Earnings were 24.68 million, a decrease of -24.60%.

Financial numbers in SEK